4.5 Review

Nanomedicine approaches to improve cancer immunotherapy

Publisher

WILEY
DOI: 10.1002/wnan.1456

Keywords

-

Funding

  1. National Institutes of Health/National Cancer Institute [R01CA178748-01, U54CA198999]
  2. NIH/NCI [R21 CA182322]
  3. National Natural Science Foundation of China [81372424]
  4. Foundation Research Project of Jiangsu Province [BK20131131]

Ask authors/readers for more resources

Significant advances have been made in the field of cancer immunotherapy by orchestrating the body's immune system to eradicate cancer cells. However, safety and efficacy concerns stemming from the systemic delivery of immunomodulatory compounds limits cancer immunotherapies expansion and application. In this context, nanotechnology presents a number of advantages, such as targeted delivery to immune cells, enhanced clinical outcomes, and reduced adverse events, which may aid in the delivery of cancer vaccines and immunomodulatory agents. With this in mind, a diverse range of nanomaterials with different physicochemical characteristics have been developed to stimulate the immune system and battle cancer. In this review, we will focus on some recent developments and the potential advantages of utilizing nanotechnology within the field of cancer immunotherapy. (C) 2017 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available